DataMEDS AI, Inc. (MEDS)
NASDAQ: MEDS · Real-Time Price · USD
1.680
+0.815 (94.15%)
Sep 15, 2026, 3:50 PM EDT - Market open
DataMEDS AI Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 2.46 | 0.04 | 1.03 | 0 | - |
Cash & Short-Term Investments | 2.46 | 0.04 | 1.03 | 0 | - |
Cash Growth | 484.93% | -95.86% | 75291.20% | - | - |
Accounts Receivable | 1.17 | 1.14 | 2.72 | - | - |
Other Receivables | 0.03 | - | 1.02 | 0.34 | - |
Receivables | 1.2 | 1.14 | 3.75 | 0.34 | - |
Inventory | 1.51 | 1.64 | 9.52 | - | - |
Prepaid Expenses | 0.47 | - | 0 | - | - |
Other Current Assets | - | - | 0.88 | - | - |
Total Current Assets | 5.63 | 2.82 | 15.17 | 0.34 | - |
Property, Plant & Equipment | 0.89 | 1.2 | 1.92 | - | - |
Goodwill | 14.19 | 14.19 | 16.22 | - | - |
Other Intangible Assets | 11.95 | 12.17 | 22.36 | - | - |
Other Long-Term Assets | 0.09 | 0.09 | 1.52 | - | - |
Total Assets | 32.76 | 30.46 | 57.33 | 0.34 | - |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 12.64 | 11.69 | 6.33 | 1.04 | 0.01 |
Accrued Expenses | 6.81 | 5.74 | 3.96 | 1.78 | - |
Short-Term Debt | - | 3.24 | 5.67 | - | - |
Current Portion of Long-Term Debt | 19.21 | 7.64 | 6.26 | - | - |
Current Portion of Leases | 0.57 | 0.57 | 0.52 | - | - |
Current Unearned Revenue | 0.03 | 0.49 | 0.25 | - | - |
Other Current Liabilities | 0.17 | 0.41 | 15.05 | 0.07 | - |
Total Current Liabilities | 39.41 | 29.78 | 38.05 | 2.89 | 0.01 |
Long-Term Debt | 12.6 | 12.6 | 11.46 | 0.35 | - |
Long-Term Leases | 0.25 | 0.53 | 1.1 | - | - |
Total Liabilities | 52.26 | 42.91 | 50.6 | 3.24 | 0.01 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0 | 0.01 | 0.01 | 0 | - |
Additional Paid-In Capital | 117.63 | 98.57 | 16.49 | - | - |
Retained Earnings | -137.14 | -111.03 | -9.76 | -2.9 | -0.01 |
Comprehensive Income & Other | - | - | - | -0 | - |
Shareholders' Equity | -19.5 | -12.45 | 6.73 | -2.9 | -0.01 |
Total Liabilities & Equity | 32.76 | 30.46 | 57.33 | 0.34 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 32.62 | 24.58 | 25 | 0.35 | - |
Net Cash (Debt) | -30.17 | -24.54 | -23.97 | -0.35 | - |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -14.94 | -17.29 | -25.36 | -0.39 | - |
Filing Date Shares Outstanding | 3.06 | 2.1 | 1.04 | - | - |
Total Common Shares Outstanding | 2.84 | 2.03 | 1.02 | - | - |
Working Capital | -33.78 | -26.96 | -22.88 | -2.55 | -0.01 |
Book Value Per Share | -6.88 | -6.14 | 6.60 | - | - |
Tangible Book Value | -45.65 | -38.81 | -31.85 | -2.9 | -0.01 |
Tangible Book Value Per Share | -16.09 | -19.15 | -31.19 | - | - |
Machinery | 0.74 | 0.74 | 0.74 | - | - |
Leasehold Improvements | 0.77 | 0.77 | 0.77 | - | - |